Cardioprotection from ischemia-reperfusion injury due to Ras-GTPase inhibition is attenuated by glibenclamide in the globally ischemic heart

Cell Biochemistry and Function

Volumn 25, Issue 4, 2007, Pages 455-461

  Al Rashdan, Ibrahim ^a   Canatan, Halit ^a   Al Maghrebi, May ^a   Yousif, Mariam H M ^a   Khan, Shah A ^a   Benter, Ibrahim F ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

FPT III; Glibenclamide; Ischemia reperfusion; Pre conditioning; Signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; POTASSIUM CHANNEL BLOCKING AGENT; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOTONIC AGENTS; GLYBURIDE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; PHOSPHONIC ACIDS; RAS PROTEINS; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT;

RATTUS;

EID: 34447544087     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1353     Document Type: Article

References (30)

1. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001; 81: 153-208.
2. Macara IG, Lounsbury KM, Richards SA, McKiernan C, Bar-Sagi D. The Ras superfamily of GTPases. FASEB J 1996; 10: 625-630.
3. Abe J, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 1998; 8: 59-64.
4. Takeishi Y, Abe J, Lee JD, Kawakatsu H, Walsh RA, Berk BC. Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts. Circ Res 1999; 85: 1164-1172.
5. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000; 62: 79-109.
6. Abe J, Okuda M, Huang Q, Yoshizumi M, Berk BC. Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras. J Biol Chem 2000; 275: 1739-1748.
7. Marshall CJ. Ras effectors. Curr Opin Cell Biol 1996; 8: 197-204.
8. Muthalif MM, Benter IF, Karzoun N, et al. 20- Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 1998; 95: 12701-12706.
9. Muthalif MM, Karzoun NA, Gaber L, et al. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000; 36: 604-609.
10. Muthalif MM, Parmentier JH, Benter IF, et al. Ras/mitogen- activated protein kinase mediates norepinephrine-induced phospholipase D activation in rabbit aortic smooth muscle cells by a phosphorylation-dependent mechanism. J Pharmacol Exp Ther 2000; 293: 268-274.
11. Muthalif MM, Benter IF, Khandekar Z, et al. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt- induced hypertension. Hypertension 2000; 35: 457-463.
12. 2+/calmodulin-dependent protein kinase II, improves recovery of cardiac function in the globally ischemic heart. Mol Cell Biochem 2004; 259: 35-42.
13. Benter IF, Juggi JS, Khan I, Yousif MH, Canatan H, Akhtar S. Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GTPase, Ca2+/calmodulin-dependent protein kinase II and epidermal growth factor receptor. Mol Cell Biochem 2005; 268: 175-183.
14. Benter IF, Francis I, Khan I, et al. Signal transduction involving Ras-GTPase contributes to development of hypertension and end-organ damage in spontaneously hypertensive rats-treated with L-NAME. Pharmacol Res 2005; 52: 401-412.
15. Driamov S, Bellahcene M, Ziegler A, et al. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels. Basic Res Cardiol 2004; 99: 299-308.
16. Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med 1991; 42: 225-246.
17. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 2001; 89: 273-278.
18. Cuda G, Paterno R, Ceravolo R, et al. Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation 2002; 105: 968-974.
19. Daemen MA, van't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104: 541-549.
20. Sabbatini M, Santillo M, Pisani A, et al. Inhibition of Ras/ ERK1/2 signalling protects against post-ischemic renal injury. Am J Physiol Renal Physiol 2006; 290(6): F1408-F1415.
21. Santillo M, Mondola P, Seru R, et al. Opposing functions of Ki- and Ha-Ras genes in the regulation of redox signals. Curr Biol 2001; 11: 614-619.
22. Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reperfusion injury. Ann NY Acad Sci 2005; 1047: 248-258.
23. Gross GJ. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol 1995; 90: 85-88.
24. Pollesello P, Mebazaa A. ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction. Curr Opin Crit Care 2004; 10: 436-441.
25. Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K + channel blocker. Circulation 1994; 90: 700-705.
26. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003; 83: 1113-1151.
27. Asano G, Takashi E, Ishiwata T, et al. Pathogenesis and protection of ischemia and reperfusion injury in myocardium. J Nippon Med Sch 2003; 70: 384-392.
28. Yatani A, Okabe K, Polakis P, Halenbeck R, McCormick F, Brown AM. Ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K + channels. Cell 1990; 61: 769-776.
29. Yatani A, Quilliam LA, Brown AM, Bokoch GM. Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K + channels. J Biol Chem 1991; 266: 22222-22226.
30. Martin GA, Yatani A, Clark R, et al. GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K + channel currents. Science 1992; 255: 192-194.